Clinical Intervention Psychosis and Addiction (KLIPS)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by University of Cologne.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University of Cologne
ClinicalTrials.gov Identifier:
NCT01411566
First received: March 2, 2011
Last updated: August 5, 2011
Last verified: February 2011
  Purpose

The purpose of this study is to evaluate an integrative therapeutic concept for schizophrenic patients with comorbid substance use disorder.


Condition Intervention Phase
Psychosis
Substance Abuse
Behavioral: Skills trainig for patients with dual diagnosis
Behavioral: regular treatment
Phase 0

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Evaluation of an Integrative Therapeutic Concept for Schizophrenic Patients With Comorbid Substance Use Disorder

Resource links provided by NLM:


Further study details as provided by University of Cologne:

Primary Outcome Measures:
  • Substance use [ Time Frame: one year ] [ Designated as safety issue: No ]
  • Substance use [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Substance use [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change in drug use motivation [ Time Frame: 3 months ] [ Designated as safety issue: No ]
  • Change in drug use motivation [ Time Frame: 6 months ] [ Designated as safety issue: No ]
  • Change in drug use motivation [ Time Frame: 1 year ] [ Designated as safety issue: No ]

Estimated Enrollment: 122
Study Start Date: January 2011
Estimated Study Completion Date: December 2011
Estimated Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Treatment Behavioral: Skills trainig for patients with dual diagnosis
Skills trainig for patients with dual diagnosis
Active Comparator: Control Behavioral: regular treatment
regular treatment

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Schizophrenia
  • Addiction
  • Written statement of agreement
  • Majority

Exclusion Criteria:

  • Acute psychosis
  • Further neuropsychiatric disorder
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01411566

Locations
Germany
LVR Clinic Cologne - Academic Clinic of the University of Cologne Recruiting
Cologne, Germany, 51109
Contact: Joerg Daumann, PhD    +49 221 478 ext 87113    joerg.daumann@uk-koeln.de   
Sub-Investigator: Susanne Koenig, Diploma         
Sponsors and Collaborators
University of Cologne
Investigators
Study Chair: Joerg Daumann, PhD University of Cologne
  More Information

No publications provided

Responsible Party: Dr. Joerg Daumann, PhD, University of Cologne
ClinicalTrials.gov Identifier: NCT01411566     History of Changes
Other Study ID Numbers: Koeln-Fortune 104/2010
Study First Received: March 2, 2011
Last Updated: August 5, 2011
Health Authority: Germany: Federal Ministry of Education and Research

Keywords provided by University of Cologne:
KLIPS

Additional relevant MeSH terms:
Mental Disorders
Psychotic Disorders
Substance-Related Disorders
Schizophrenia and Disorders with Psychotic Features

ClinicalTrials.gov processed this record on July 23, 2014